Skip to content

Drug interactions

Methyldopa + Olopatadine intranasal

Severity: Moderate

Methyldopa and Olopatadine intranasal: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Methyldopa can cause drowsiness, and intranasal olopatadine is a sedating antihistamine that may cause somnolence. Together they may add to daytime sedation and reduce psychomotor performance, although the effect is usually modest.

What this interaction means in plain words

Methyldopa and Olopatadine intranasal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Additive central nervous system depression from two agents with sedative properties.

What to do

Counsel the patient about drowsiness and driving or operating machinery, particularly when starting therapy. Reduce the dose or choose a non-sedating alternative if sedation becomes troublesome.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Methyldopa and Olopatadine intranasal, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Methyldopa with Olopatadine intranasal?

MediHelp rates the interaction as moderate. Methyldopa and Olopatadine intranasal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Methyldopa can cause drowsiness, and intranasal olopatadine is a sedating antihistamine that may cause somnolence. Together they may add to daytime sedation and reduce psychomotor performance, although the effect is usually modest.

How serious is the interaction between Methyldopa and Olopatadine intranasal?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Counsel the patient about drowsiness and driving or operating machinery, particularly when starting therapy. Reduce the dose or choose a non-sedating alternative if sedation becomes troublesome.

What other medicines interact with Methyldopa?

MediHelp also lists interactions of Methyldopa with, for example, Tranylcypromine, Iobenguane i, Lofexidine. The full list is on the Methyldopa page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in